EMA Authorised: Xoanacyl (ferric citrate coordination complex) — Averoa

View source ↗

Summary

EMA authorised Xoanacyl, a ferric citrate coordination complex, for the treatment of iron deficiency and to manage hyperphosphatemia in chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia
• Iron Deficiency

Drugs mentioned

• Xoanacyl (ferric citrate coordination complex)

Snippet

Status: Authorised. Therapeutic area: Iron Deficiencies;Renal Insufficiency, Chronic;Hyperphosphatemia. MAH: Averoa. Decision date: 11/06/2025